Acessibilidade / Reportar erro

COVID-19 in patients treated with intravesical Bacillus Calmette Guerin

Dear Editor,

We would like to share ideas on the publication “Investigation of the frequency of COVID-19 in patients treated with intravesical BCG”. Karabay et al. concluded that “Intravesical BCG administration does not decrease the frequency of COVID-19 infection11. Karabay O, Köse O, Tocoglu A, Uysal B, Dheir H, Yaylaci S, et al. Investigation of the frequency of COVID-19 in patients treated with intravesical BCG. Rev Assoc Med Bras (1992). 2020;66Suppl 2(Suppl 2):91-5. https://doi.org/10.1590/1806-9282.66.S2.91
https://doi.org/10.1590/1806-9282.66.S2....
.” Indeed, effect of BCG on COVID-19 is an interesting issue. While some authors show that BCG might be useful, others present totally discordant ideas. A common consideration on any report of the BCG effect on COVID-19 is the confounding factor. Theoretically, by molecular mechanism via tertiary lymphoid structure (TLS) organogenesis22. O'Neill LAJ, Netea MG. BCG-induced trained immunity: can it offer protection against COVID-19? Nat Rev Immunol. 2020;20(6):335-7. https://doi.org/10.1038/s41577-020-0337-y
https://doi.org/10.1038/s41577-020-0337-...
,33. Koti M, Morales A, Graham CH, Siemens DR. BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy. J Immunother Cancer. 2020;8(2):e001119. https://doi.org/10.1136/jitc-2020-001119
https://doi.org/10.1136/jitc-2020-001119...
, BCG might be useful. Trained immunity might occur after BCG vaccination. However, it is necessary to allow a period for immune training. From the observation by Karabay et al.11. Karabay O, Köse O, Tocoglu A, Uysal B, Dheir H, Yaylaci S, et al. Investigation of the frequency of COVID-19 in patients treated with intravesical BCG. Rev Assoc Med Bras (1992). 2020;66Suppl 2(Suppl 2):91-5. https://doi.org/10.1590/1806-9282.66.S2.91
https://doi.org/10.1590/1806-9282.66.S2....
, it might be interesting to assess time effect. Additionally, many confounding factors can affect the observed frequency of COVID-1944. Wiwanitkit V. COVID-19 death and BCG vaccination. Tuberc Respir Dis (Seoul). 2021;84(1):84. https://doi.org/10.4046/trd.2020.0115
https://doi.org/10.4046/trd.2020.0115...
. In the report by Karabay et al.11. Karabay O, Köse O, Tocoglu A, Uysal B, Dheir H, Yaylaci S, et al. Investigation of the frequency of COVID-19 in patients treated with intravesical BCG. Rev Assoc Med Bras (1992). 2020;66Suppl 2(Suppl 2):91-5. https://doi.org/10.1590/1806-9282.66.S2.91
https://doi.org/10.1590/1806-9282.66.S2....
, the number of subjects are also few. A larger study might give different results.

  • Funding: none.

REFERENCES

  • 1.
    Karabay O, Köse O, Tocoglu A, Uysal B, Dheir H, Yaylaci S, et al. Investigation of the frequency of COVID-19 in patients treated with intravesical BCG. Rev Assoc Med Bras (1992). 2020;66Suppl 2(Suppl 2):91-5. https://doi.org/10.1590/1806-9282.66.S2.91
    » https://doi.org/10.1590/1806-9282.66.S2.91
  • 2.
    O'Neill LAJ, Netea MG. BCG-induced trained immunity: can it offer protection against COVID-19? Nat Rev Immunol. 2020;20(6):335-7. https://doi.org/10.1038/s41577-020-0337-y
    » https://doi.org/10.1038/s41577-020-0337-y
  • 3.
    Koti M, Morales A, Graham CH, Siemens DR. BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy. J Immunother Cancer. 2020;8(2):e001119. https://doi.org/10.1136/jitc-2020-001119
    » https://doi.org/10.1136/jitc-2020-001119
  • 4.
    Wiwanitkit V. COVID-19 death and BCG vaccination. Tuberc Respir Dis (Seoul). 2021;84(1):84. https://doi.org/10.4046/trd.2020.0115
    » https://doi.org/10.4046/trd.2020.0115

Publication Dates

  • Publication in this collection
    18 Oct 2021
  • Date of issue
    Aug 2021

History

  • Received
    11 June 2021
  • Accepted
    14 July 2021
Associação Médica Brasileira R. São Carlos do Pinhal, 324, 01333-903 São Paulo SP - Brazil, Tel: +55 11 3178-6800, Fax: +55 11 3178-6816 - São Paulo - SP - Brazil
E-mail: ramb@amb.org.br